Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ATHE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ATHE

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Alterity Therapeutics Ltd

ATHE
Current price
3.89 USD +0.026 USD (+0.68%)
Last closed 4.11 USD
ISIN US02155X1063
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 61 434 112 USD
Yield for 12 month +90.69 %
1Y
3Y
5Y
10Y
15Y
ATHE
21.11.2021 - 28.11.2021

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia. Address: 350 Collins Street, Melbourne, VIC, Australia, 3000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.00 USD

P/E Ratio

Dividend Yield

Financials ATHE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ATHE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+2 633 016 USD

Last Year

+2 565 572 USD

Current Quarter

+526 017 USD

Last Quarter

+526 017 USD

Current Year

+2 492 626 USD

Last Year

+2 378 826 USD

Current Quarter

+505 186 USD

Last Quarter

+505 186 USD
EBITDA -20 493 620 USD
Operating Margin TTM -469.68 %
Price to Earnings
Return On Assets TTM -78.37 %
PEG Ratio
Return On Equity TTM -155.77 %
Wall Street Target Price 11.00 USD
Revenue TTM 3 724 486 USD
Book Value 0.0010 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -15.50 %
Dividend Yield
Gross Profit TTM 3 543 552 USD
Earnings per share -1.84 USD
Diluted Eps TTM -1.84 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation ATHE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 113.99
Price Sales TTM 16.71
Enterprise Value EBITDA 0.75
Price Book MRQ 11.69

Technical Indicators ATHE

For 52 Weeks

1.00 USD 5.87 USD
50 Day MA 4.18 USD
Shares Short Prior Month 127 745
200 Day MA 3.00 USD
Short Ratio 5.59
Shares Short 116 787
Short Percent 0.79 %